Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Argus Downgrades Zimmer Biomet Holdings to Hold From Buy

11/23/2021 | 08:55am EST


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
01/24Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Pla..
AQ
01/21Health Care Stocks Retreat This Afternoon
MT
01/21Zimmer Biomet's Spinoff Plan for Dental, Spine Businesses on Track with Regulatory Fili..
MT
01/21Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Pla..
PR
01/21Needham Trims Zimmer Biomet Holdings' Price Target to $155 From $158; Buy Rating Kept
MT
01/19Wells Fargo Cuts Zimmer Biomet Holdings to Underweight From Equalweight; Price Target t..
MT
01/11NORTH AMERICAN MORNING BRIEFING : Inflation, Rate -3-
DJ
01/10Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2021 Financial Re..
PR
01/10BTIG Downgrades Zimmer Biomet Holdings to Neutral From Buy
MT
01/10NORTH AMERICAN MORNING BRIEFING : Yields Rise, -3-
DJ
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7 865 M - -
Net income 2021 839 M - -
Net Debt 2021 6 461 M - -
P/E ratio 2021 31,0x
Yield 2021 0,79%
Capitalization 25 328 M 25 328 M -
EV / Sales 2021 4,04x
EV / Sales 2022 3,73x
Nbr of Employees 20 000
Free-Float 66,8%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 121,24 $
Average target price 156,84 $
Spread / Average Target 29,4%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-4.57%25 328
ABBOTT LABORATORIES-14.42%206 551
MEDTRONIC PLC-0.26%138 731
BECTON, DICKINSON AND COMPANY0.96%71 600
HOYA CORPORATION-18.59%44 518
BAXTER INTERNATIONAL INC.-1.41%42 374